Wendy Hayes

4.4k citations

54 papers · 2.6k indexed · 1 hit paper · h-index 19

Oncology top 2%
Pulmonary and Respiratory Medicine top 2%
Radiology, Nuclear Medicine and Imaging top 2%
Surgery top 10%
Molecular Biology

Co-authors: Otto S. Hoekstra Lawrence H. Schwartz Alice P. Chen Patrick Therasse Jan Bogaerts Sumithra J. Mandrekar Lesley Seymour Janet Dancey
Topics: Radiomics and Machine Learning in Medical Imaging (19 papers)Medical Imaging Techniques and Applications (18 papers)Lung Cancer Treatments and Mutations (11 papers)
Cited by: Oncology Radiology, Nuclear Medicine and Imaging Pulmonary and Respiratory Medicine
Journals: Journal of Clinical Oncology PLoS ONE Cancer
Partner nations: United States Netherlands Germany

In The Last Decade

Wendy Hayes

53 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

RECIST 1.1—Update and clarification: From the RECIST committee

2016 1.2k citations Lawrence H. Schwartz, Saskia Litière et al. European Journal of Cancer profile →

Peers

Countries citing papers authored by Wendy Hayes

Since Specialization

Citations

This map shows the geographic impact of Wendy Hayes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy Hayes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy Hayes more than expected).

Fields of papers citing papers by Wendy Hayes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy Hayes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy Hayes. The network helps show where Wendy Hayes may publish in the future.

Co-authorship network of co-authors of Wendy Hayes

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy Hayes. A scholar is included among the top collaborators of Wendy Hayes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy Hayes. Wendy Hayes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A prospective observational study investigating pelvic floor muscle training effects on obstructed defaecation in female patients 2026 ·(unknown),(unknown),(unknown),Wendy Hayes,David Z. Lubowski,Vicki Patton	0
2	Six Year Extension Study of Patients From a Randomised Clinical Trial Comparing Venefit, Radiofrequency Induced Thermal Therapy, and Endovenous Radiofrequency Ablation for Treatment of Incompetent Great Saphenous Veins 2023 ·European Journal of Vascular and Endovascular Surgery ·Isaac Nyamekye,(unknown),(unknown),Wendy Hayes	1
3	Molecular Imaging and the PD-L1 Pathway: From Bench to Clinic 2021 ·Frontiers in Oncology ·David Leung,Samuel J. Bonacorsi,R. Adam Smith,Wolfgang Weber,Wendy Hayes	14
4	Synthesis and Preclinical Evaluation of a ⁶⁸Ga-Labeled Adnectin, ⁶⁸Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression 2021 ·Journal of Nuclear Medicine ·Stephanie Robu,Antonia Richter,(unknown),Christof Seidl,David Leung,Wendy Hayes,Daniel N. Cohen,Paul E. Morin,David J. Donnelly,Daša Lipovšek,Samuel J. Bonacorsi,Adam W. Smith,Katja Steiger,(unknown),Angela M. Krackhardt,Wolfgang Weber	27
5	Identification of Non–Small Cell Lung Cancer Sensitive to Systemic Cancer Therapies Using Radiomics 2020 ·Clinical Cancer Research ·Laurent Dercle,Matthew Fronheiser,Lin Lü,Shuyan Du,Wendy Hayes,David Leung,Amit Roy,Julia Wilkerson,Pingzhen Guo,Antonio Tito Fojo,Lawrence H. Schwartz,Binsheng Zhao	128
6	THU0095 IMPACT OF BASELINE EROSION SCORE ON RESPONSE TO TREATMENT AND FUTURE RADIOLOGICAL DAMAGE IN AVERT-2, A RANDOMISED PHASE IIIB STUDY OF ABATACEPT IN MTX-NAÏVE, ANTI-CITRULLINATED PROTEIN ANTIBODY–POSITIVE (ACPA+) PATIENTS WITH EARLY RA 2020 ·Annals of the Rheumatic Diseases ·Chahin Pachaï,Seán Connolly,(unknown),Yoshiya Tanaka,Vivian P. Bykerk,T. Huizinga,Gustavo Citera,(unknown),Rosa S. Wong,Kuo‐How Huang,Shizheng Du,Wendy Hayes,Changwei W. Wu,R. Fleischmann,Paul Emery	2
7	Quantification of PD-L1 Expression with ¹⁸F-BMS-986192 PET/CT in Patients with Advanced-Stage Non–Small Cell Lung Cancer 2020 ·Journal of Nuclear Medicine ·Marc C. Huisman,Anna-Larissa N. Niemeijer,Albert D. Windhorst,Robert C. Schuit,David Leung,Wendy Hayes,Alex J. Poot,Idris Bahce,Teodora Radonic,Daniela E. Oprea‐Lager,Otto S. Hoekstra,Erik Thunnissen,N. Harry Hendrikse,Egbert F. Smit,Adrianus J. de Langen,Ronald Boellaard	60
8	Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease 2017 ·PLoS ONE ·Viktor Martyanov,Grace Hyun J. Kim,Wendy Hayes,Shuyan Du,Bishu Ganguly,Oumar Sy,(unknown),Galina S. Bogatkevich,Gary L. Schieven,Elena Schiopu,Roberta Gonçalves Marangoni,Jonathan Goldin,Michael L. Whitfield,John Varga	58
9	Whole body PD-1 and PD-L1 PET in pts with NSCLC 2017 ·Annals of Oncology ·(unknown),Egbert F. Smit,Idris Bahce,O. S. Hoekstra,(unknown),Guus AMS van Dongen,Albert D. Windhorst,N. Harry Hendrikse,Alex J. Poot,Daniëlle J. Vugts,David Leung,Wendy Hayes,R. Adam Smith,L. Wilson,Erik Thunnissen,J. De Langen	3
10	Radiosynthesis and preclinical PET evaluation of 89Zr-nivolumab (BMS-936558) in healthy non-human primates 2017 ·Bioorganic & Medicinal Chemistry ·Erin L. Cole,Joon‐Young Kim,David J. Donnelly,R. Adam Smith,Daniel N. Cohen,Virginie Lafont,Paul E. Morin,Richard Y.‐C. Huang,Patrick L Chow,Wendy Hayes,Samuel J. Bonacorsi	76
11	RECIST 1.1—Update and clarification: From the RECIST committeebreakdown → 2016 ·European Journal of Cancer ·Lawrence H. Schwartz,Saskia Litière,Elisabeth G.E. de Vries,Robert Ford,Stephen J. Gwyther,Sumithra J. Mandrekar,Lalitha Shankar,Jan Bogaerts,Alice P. Chen,Janet Dancey,Wendy Hayes,F. Stephen Hodi,Otto S. Hoekstra,Erich P. Huang,Nancy U. Lin,Yan Liu,Patrick Therasse,Jedd D. Wolchok,Lesley Seymour	1206
12	RECIST 1.1 – Standardisation and disease-specific adaptations: Perspectives from the RECIST Working Group 2016 ·European Journal of Cancer ·Lawrence H. Schwartz,Lesley Seymour,Saskia Litière,Robert Ford,Stephen J. Gwyther,Sumithra J. Mandrekar,Lalitha Shankar,Jan Bogaerts,Alice P. Chen,Janet Dancey,Wendy Hayes,F. Stephen Hodi,Otto S. Hoekstra,Erich P. Huang,Nancy U. Lin,Yi Yan,Patrick Therasse,Jedd D. Wolchok,Elisabeth G.E. de Vries	221
13	Repeatability of Metabolically Active Tumor Volume Measurements with FDG PET/CT in Advanced Gastrointestinal Malignancies: A Multicenter Study 2014 ·Radiology ·Virginie Frings,Floris H. P. van Velden,Linda Velasquez,Wendy Hayes,Peter M. van de Ven,Otto S. Hoekstra,Ronald Boellaard	78
14	Measuring response to therapy using FDG PET: semi-quantitative and full kinetic analysis 2011 ·European Journal of Nuclear Medicine and Molecular Imaging ·Patsuree Cheebsumon,Linda Velasquez,C. Hoekstra,Wendy Hayes,Reina W. Kloet,Nikie J. Hoetjes,Egbert F. Smit,Otto S. Hoekstra,Adriaan A. Lammertsma,Ronald Boellaard	59
15	Measurement of metabolic tumor volume: static versus dynamic FDG scans 2011 ·EJNMMI Research ·Patsuree Cheebsumon,Floris H. P. van Velden,Maqsood Yaqub,C. Hoekstra,Linda Velasquez,Wendy Hayes,Otto S. Hoekstra,Adriaan A. Lammertsma,Ronald Boellaard	25
16	Phase I dose-escalation study to determine the safety, pharmacokinetics and pharmacodynamics of brivanib alaninate in combination with full-dose cetuximab in patients with advanced gastrointestinal malignancies who have failed prior therapy 2011 ·British Journal of Cancer ·Christopher R. Garrett,Lillian L. Siu,Anthony B. El-Khoueiry,Jan Buter,Caio Rocha‐Lima,John L. Marshall,Patricia LoRusso,Pierre Major,(unknown),(unknown),(unknown),Wendy Hayes,David Feltquate,S. Syed,(unknown),Georgia Kollia,Susan Galbraith,Dimitry S.A. Nuyten	23
17	Downregulation of ¹⁸F-FDG Uptake in PET as an Early Pharmacodynamic Effect in Treatment of Non–Small Cell Lung Cancer with the mTOR Inhibitor Everolimus 2009 ·Journal of Nuclear Medicine ·Lucia Nogová,Ronald Boellaard,Carsten Kobe,Nikie J. Hoetjes,Thomas Zander,(unknown),Saša Dimitrijević,Theodore C. Pellas,W. Eschner,Katja Schmidt,Christopher Bangard,Wendy Hayes,Roman K. Thomas,Markus Dietlein,Giuseppe Giaccone,Otto S. Hoekstra,Adriaan A. Lammertsma,Jürgen Wolf	24
18	The development of an Incontinence Treatment Motivation Questionnaire for patients undergoing pelvic floor physiotherapy in the treatment of stress incontinence 2009 ·International Urogynecology Journal ·(unknown),Graeme Hawthorne,(unknown),Wendy Hayes,Kate H. Moore	11
19	Volumetric CT in Lung Cancer 2009 ·Academic Radiology ·Andrew J. Buckler,P. David Mozley,Lawrence H. Schwartz,Nicholas Petrick,Michael F. McNitt‐Gray,Charles Fenimore,K.P. O’Donnell,Wendy Hayes,Han Jo Kim,Laurence P. Clarke,Daniel C. Sullivan	33
20	P1-084: Mammalian target of rapamycin (mTOR) inhibition by RAD001 in patients (pts) with reccurent non-small cell lung cancer (NSCLC): Use of 18F fluorodeoxyglucose positron-emission tomography (FDG-PET) in evaluation of the pharmacodynamic effect 2007 ·Journal of Thoracic Oncology ·Lucia Nogová,Thomas Zander,(unknown),Theodore C. Pellas,Wendy Hayes,Roman K. Thomas,Markus Dietlein,Giuseppe Giaccone,Otto S. Hoekstra,Juergen Wolf	2

About Wendy Hayes

Wendy Hayes is a scholar working on Radiology, Nuclear Medicine and Imaging, Hepatology and Oncology, having authored 54 papers that have together received 2.6k indexed citations. Recurring topics across this work include Radiomics and Machine Learning in Medical Imaging (19 papers), Medical Imaging Techniques and Applications (18 papers) and Lung Cancer Treatments and Mutations (11 papers). The work is most often cited by research in Oncology (1.1k citations), Radiology, Nuclear Medicine and Imaging (878 citations) and Pulmonary and Respiratory Medicine (1.0k citations). Wendy Hayes has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Otto S. Hoekstra, Lawrence H. Schwartz, Alice P. Chen, Patrick Therasse, Jan Bogaerts, Sumithra J. Mandrekar, Lesley Seymour, Janet Dancey, Saskia Litière and F. Stephen Hodi. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact